Pharmaceutical companies in Nigeria are more interested in trading than investing in research and development of drugs, therapies, and treatments, a BusinessDay analysis has shown.
Big pharmaceutical companies in developed countries are increasing their risk appetite for investing in untested dis
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
